Paid Clinical Trials in Rochester, NY
As of July 2026, 459 paid clinical trials are recruiting in Rochester, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Rochester offers studies at sites including University of Rochester for conditions such as Acute Myeloid Leukemia, Breast Cancer, Obesity, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Rochester
Trials by drug in Rochester
Filter results
Newly added in Rochester
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Measuring How Quickly the Eye Focuses After Sustained Viewing of Close-up Images and Videos
A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
408 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Top Research Study Locations in Rochester
Researchers run research studies in Rochester, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Rochester | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Malignant Solid Neoplasm | 162 |
| University of Rochester Medical Center | Healthy, Pulmonary Hypertension, Breathing | 106 |
| Rochester Clinical Research, LLC | Obesity, Overweight, Chronic Pain | 13 |
| Highland Hospital | Stage IVA Prostate Cancer AJCC v8, Abscess, Advanced Colorectal Carcinoma | 11 |
| Rochester General Hospital | Aortic Valve Stenosis, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | 10 |
| Pluta Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 7 |
| Wilmot Cancer Institute | Breast Cancer, Acute Leukemia, Aplastic Anemia | 7 |
| Rochester Clinical Research | Acute Migraine, Atherosclerotic Cardiovascular Disease, Crohn's Disease | 6 |
| University of Rochester Medical Center (URMC) | Adult Acute Myeloid Leukemia, Hpv, Phenylketonuria | 5 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Irritable Bowel Syndrome, Tumours, Gynecological | 4 |
| Strong Memorial Hospital | Aortic Stenosis, Atrial Fibrillation, Cardiotoxicity | 4 |
| Unity Park Ridge Campus | Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma, Muscle Invasive Ureter Urothelial Carcinoma | 3 |
| University of Rochester Medical Center Strong Memorial | Cystic Fibrosis, Cystic Fibrosis (CF) | 3 |
| University of Rochester Wilmot Cancer Institute | Angiosarcoma, Breast Cancer, Breast Neoplasms | 3 |
| Wilmot Cancer Institute Radiation Oncology at Greece | Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Pancreatic Adenocarcinoma | 3 |
| AD-CARE, University of Rochester Medical Center | Alzheimers Disease | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| American Thrombosis and Hemostasis Network | Bleeding Disorder, Connective Tissue Disorder, Factor IX Deficiency | 2 |
| Chester F. Carlson Center for Imaging Science | Distance Viewing, L- and M-cone Modulation Only, L- and S-cone Modulation Only | 2 |
| Gastroenterology Group Of Rochester, LLP | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Mayo Clinic | Lymphedema, Breast Cancer, Solid and Hematological Malignancies | 2 |
| Mt. Hope Family Center | Fetal Alcohol Spectrum Disorders, Posttraumatic Stress Disorder | 2 |
| Retina Associates of Western NY, P.C. | Epiretinal Membrane, Proliferative Diabetic Retinopathy (PDR) | 2 |
| Retina Associates of Western New York | Age Related Macular Degeneration (AMD), DME, Diabetic Macular Edema | 2 |
| Rochester Clinical Research, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
Active & Upcoming Studies in Rochester (2026)
Recruiting trials in Rochester grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (172 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia · Phase 2 · University of Rochester
Neurology & pain (31 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain · Phase 2 · Eli Lilly and Company
Cardiovascular (23 active studies)
- The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease · University of Rochester
- A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study · Phase 3 · YS Life Science Co., Ltd.
Diabetes & metabolic (17 active studies)
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity · Phase 3 · Pfizer
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
Mental health & behavior (11 active studies)
- Deaf CBT-TS to Reduce Suicide Risk · University of Rochester
- Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression · Phase 2 · University of Rochester
Eye & vision (9 active studies)
- A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study · Phase 3 · YS Life Science Co., Ltd.
- BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber · University of Rochester
Pediatric (7 active studies)
- Caffeine Optimization for Oxygen Saturation Index in ELBW Infants · Phase 2 · University of Rochester
- Tumor-Lymph Node Mapping · University of Rochester
HIV / STI (2 active studies)
- Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
- A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
Vaccines (1 active study)
- SAVE: School Ambassadors for Vaccine Education · University of Rochester
Common conditions studied in Rochester
- Acute Myeloid Leukemia (12 active studies)
- Breast Cancer (10 active studies)
- Obesity (8 active studies)
- Cancer (6 active studies)
- Heart Failure (6 active studies)
- Overweight (6 active studies)
Leading research sponsors in Rochester
- University of Rochester
- National Cancer Institute (NCI)
- Eli Lilly and Company
- SWOG Cancer Research Network
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Rochester?
There are approximately 459 recruiting clinical trials in Rochester, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Rochester pay participants?
Most recruiting trials in Rochester compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Rochester?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Rochester?
The most common conditions under active study in Rochester include Acute Myeloid Leukemia (12), Breast Cancer (10), Obesity (8), Cancer (6), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Rochester?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Rochester on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Rochester?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Rochester?
Recruiting research sites in Rochester include University of Rochester, University of Rochester Medical Center, Rochester Clinical Research, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Rochester right now?
The largest active categories in Rochester are Cancer & tumors (172), Neurology & pain (31), Cardiovascular (23). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.